COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 1662: Articles 16611-16620  | Next

Understanding the impact of the Covid-19 pandemic on delivery of rehabilitation in specialist palliative care services: An analysis of the CovPall-Rehab survey data.
Bayly, J., Bradshaw, A., Fettes, L., Omarjee, M., Talbot-Rice, H., Walshe, C., Sleeman, K. E., Bajwah, S., Dunleavy, L., Hocaoglu, M., Oluyase, A., Garner, I., Cripps, R. L., Preston, N. J., Fraser, L. K., Murtagh, F. E., Higginson, I. J., Maddocks, M.
10.1101/2021.04.13.21255380 — Posted: 2021-04-19
Mortality reduction in ICU-admitted COVID-19 patients in Suriname after treatment with convalescent plasma acquired via gravity filtration
Bihariesingh, R., Bansie, R., Froberg, J., Ramdhani, N., Mangroo, R., Bustamente, D., Diaz, E., Thakoer, I., Vreden, S., Choudhry, Z., Jansen Klomp, W., Diavatopoulos, D., Nierich, A.
10.1101/2021.04.14.21255104 — Posted: 2021-04-19
Network controllability enrichment analysis reveals that SARS-CoV-2 infection tends to target indispensable nodes of a directed human protein-protein interaction network
Lee, H.-J.
10.1101/2021.04.18.440358 — Posted: 2021-04-19
A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19
Idris, A., Davis, A., Supramaniam, A., Acharya, D., Kelly, G., Tayyer, Y., West, N., Zhang, P., McMillan, C., Soemardy, C., Ray, R., O'meally, D., Scott, T., McMillan, N., Morris, K.
10.1101/2021.04.19.440531 — Posted: 2021-04-19
Inferring the stabilization effects of SARS-CoV-2 variants on the binding with ACE2 receptor
Miotto, M., Di Rienzo, L., Gosti, G., Bo, L., Parisi, G., Piacentini, R., Boffi, A., Ruocco, G., Milanetti, E.
10.1101/2021.04.18.440345 — Posted: 2021-04-19
The SARS CoV-1 3a protein disrupts Golgi complex morphology and cargo trafficking
Gonzales, R. R., Machamer, C. E.
10.1101/2021.04.19.440492 — Posted: 2021-04-19
Molecular relationships between SARS-CoV-2 Spike protein and LIFR, a pneumonia protective IL-6 family cytokine
Ngara, M., Siwo, G. H.
10.1101/2021.04.18.440296 — Posted: 2021-04-19
Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein
Gerdol, M.
10.1101/2021.04.17.440288 — Posted: 2021-04-19 Discussion: Onsite
Low dose inocula of SARS-CoV-2 B.1.1.7 variant initiate more robust infections in the upper respiratory tract of hamsters than earlier D614G variants
Mok, B. W.-Y., Liu, H., Lau, S.-Y., Deng, S. D., Liu, S., Tam, R. C.-Y., Ng, T. T.-L., Leung, J. S.-L., Wang, P., To, K. K.-W., Chan, J. F.-W., Chan, K.-H., Yuen, K.-Y., Siu, G. K.-H., Chen, H.
10.1101/2021.04.19.440414 — Posted: 2021-04-19
SARS-CoV-2 20I/501Y.V1 variant in the hamster model
Cochin, M., Luciani, L., Touret, F., Driouich, J. S., Petit, P.-R., Moureau, G., Baronti, C., Maes, P., Boudewijns, R., Neyts, J., de Lamballerie, X., Nougairede, A.
10.1101/2021.04.19.440435 — Posted: 2021-04-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).